Navigation Links
Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
Date:7/15/2008

Ingenuity provides state-of-the-art solution for Huntington's disease research by integrating internal knowledge and curated disease content

through IPA

REDWOOD CITY, Calif., July 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, and CHDI Foundation, Inc., a non-profit organization focused on discovering and developing drugs to treat Huntington's disease, today announced a multi-year agreement for CHDI to use IPA as a platform to integrate Ingenuity-curated information relevant to Huntington's disease. CHDI researchers will be able to leverage this knowledge using the complete set of analysis tools and structured knowledge already available in IPA.

Ingenuity is advancing the development of disease-specific solutions by allowing organizations such as CHDI to use IPA as a platform to access both internal documents and disease-specific knowledge. This new type of solution addresses longstanding information management challenges by providing a uniform platform to capture and access diverse information resources, allowing for more efficient knowledge management and improved business value. This groundbreaking solution is made possible by the Ingenuity Ontology, which organizes and structures the knowledge in IPA and which can be applied broadly across internal information and customized with disease-specific knowledge for corporate use as well as that of academic and government institutions.

"The way organizations leverage knowledge can be a significant advantage in advancing discovery," said Robert Pacifici, Ph.D., Chief Scientific Officer for CHDI. "Using IPA provides us with a single entry point for Huntington's disease-specific content so that this knowledge is leveraged effectively across our organization."

"We are excited to work with CHDI to provide them with a solution tailored to their requirements," stated Sean Scott, SVP Commercial Operations, Ingenuity Systems. "Our customers frequently request solutions that are specific to their disease-focused research programs. We are providing CHDI with custom content, so all of their knowledge can be integrated and analyzed within a common environment. CHDI staff will have higher confidence they are utilizing all the available information to effectively formulate hypotheses, verify experimental results, and share research outcomes."

About CHDI Foundation, Inc.

CHDI Foundation is a non-profit organization supporting an international network of academic and industrial research laboratories pursuing novel treatments for Huntington's disease. The organization's virtual pharma approach is designed to bring the right collaborators together to identify and address critical scientific issues and move drug candidates to clinical evaluation as quickly as possible. For more information about CHDI and its collaborative programs, please contact Bonnie Lee La Madeleine at 310.342.5524.

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions for the exploration, interpretation, and analysis of life science information. All of Ingenuity's products and services have one common goal -- to help life science researchers generate maximum value from all types of biological and chemical knowledge. Ingenuity offers a broad and flexible range of solutions that can be tailored to needs of various clients, including academic and therapeutic area researchers, computational biologists and informatics departments, and suppliers in the life sciences industry. All of the products leverage the Ingenuity Knowledge Base, the largest data base of its kind, which houses the biological and chemical relationships extracted from scientific literature. The information is uniquely structured so scientists can ask complex biological questions to gain rapid insight into their experimental data or create relevant biological models to move forward in their research. Today, Ingenuity's solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, and academic research institutions worldwide. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, Australia, and Japan. http://www.ingenuity.com.


'/>"/>
SOURCE Ingenuity Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ingenuitys Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference
2. Ingenuity Systems Delivers Key Milestones in FDA Collaboration to Facilitate Genomic Data Review
3. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
4. Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc.
5. IgeaCare Systems USA, Inc. enters distribution agreement with Jenne Distributors, Inc.
6. Fox Learning Systems Selects Prymaks Discovery-180(TM) Technology Assessment to Guide Search for New LMS
7. Fragmented Los Angeles Hospital Market Provides Health Systems with Little Leverage to Negotiate Higher Reimbursement
8. SouthMed, Inc. and Vocollect Healthcare Systems Announce Reseller Agreement
9. NOTES research activities increase with grants from Olympus medical Systems totaling $1 million
10. Milton Frank Appointed COO of Life Recovery Systems
11. Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio , founder ... national #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer ... Gives Back initiative, and we’re very pleased with the participation in every ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims to redefine ... are both engaging and easy to use. Coming off the heels of a ... today its plans to roll out new AI-powered self-service enhancements to help organizations ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... -- External Defibrillators, Implantable Cardioverter Defibrillators, ... Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, ... The global defibrillators market is expected ... 2016-2020 and CAGR of 5.1% from 2020-2026. The ... of 5.2% from 2016 to 2026. The market ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... forecasts the global optical transceiver market to grow at a CAGR ... covers the present scenario and the growth prospects of the global ... report considers the revenue generated from the shipment of optical transceivers ...
(Date:12/9/2016)... Dec. 9, 2016 Mitsubishi Tanabe Pharma Corporation ... Representative Director, CEO: Dr. Masayuki Mitsuka ) has ... (ALS) given edaravone intravenously in 10-14 day cycles for ... by the ALS Functional Rating Scale-Revised (ALSFRS-R). The data ... on ALS/MND in Dublin, Ireland . ...
Breaking Medicine Technology: